Drug Stores: China Nepstar Chain Drugstore (NYSE:NPD), PharMerica Corporation (NYSE:PMC), Walgreen Company (NYSE:WAG), CVS Caremark Corporation (NYSE:CVS)

FB Nasdaq FB Facebook

China Nepstar Chain Drugstore Ltd. (ADR) (NYSE:NPD), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2013. China Nepstar Chain Drugstore Ltd. (ADR) (NYSE:NPD) stock performance was 1.98% in last session and finished the day at $2.57. Traded volume was 97.40K shares in the last session and the average volume of the stock remained 207.33K shares. The beta of the stock remained 2.07.

PharMerica Corporation (NYSE:PMC), a firm in the Medical Output/Home Care industry, which could be a great candidate for another beat. This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, PMC has beaten estimates by at least 50% in both cases, suggesting it has a nice short-term history of crushing expectations. PharMerica Corporation (NYSE:PMC) rose 3.26 percent to $26.60 Tuesday on volume of 232.90K shares. The intra-day range of the stock was $25.75 to $27.08. PharMerica Corporation (NYSE:PMC) has a market capitalization of $785.69million.

Currently there are about 1,600 walk-in medical clinics across the country in drug and big-box stores and supermarkets like CVS, Walgreen Company (NYSE:WAG) Target and Kroger. Walgreens has more than 400 Healthcare Clinics and plans to open nearly 100 new locations this year. Target currently operates 70 clinics in its stores with plans for 10 more this year. Walgreen Company (NYSE:WAG)’s stock on Apr 08, 2014 reported a decrease of -1.97% to the closing price of $63.82. Its fifty two weeks range is $43.31 -$69.84. The total market capitalization recorded $60.91billion. The overall volume in the last trading session was 7.92million shares. In its share capital, WAG has 954.33million outstanding shares.

CVS Caremark Corporation (NYSE:CVS) has agreed to pay $20 million to settle charges by the Securities and Exchange Commission that it misled investors about “significant financial setbacks” suffered by the company and artificially boosting its financial performance. On Tuesday, shares of CVS Caremark Corporation (NYSE:CVS) dropped -0.88% to close the day at $73.18. Company return on investment (ROI) is 10.00% and its monthly performance is recorded as -0.53%. CVS Caremark Corporation (NYSE:CVS) quarterly revenue growth is 5.46%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone